U.S. flag
        An official website of the United States government
          Here’s how you know

      Official websites use .gov
                A
                .gov
                website belongs to an official government organization in the United States.
          Secure .gov websites use HTTPS
                A lock
                  (
                  
                  )
                   or
                  https://
                   means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.Search
                Menu
    
                      Información en Español
                      Search NINDSSearch NINDS
            

            Main navigation
  

        
              Health Information
                                     Toggle Health Information Dropdown
                                Disorders
                Clinical Trials
                Patient & Caregiver Education
                Public Education
                Support Resources
                Funding
                                     Toggle Funding Dropdown
                                Find Funding Opportunities
                About Funding
                Preparing Your Application
                After You Submit
                Determining Your Funding Likelihood
                Manage Your Award
                NINDS Small Business Program
                Training & Career Development
                Current Research
                                     Toggle Current Research Dropdown
                                Coronavirus and NINDS
                Focus on Disorders
                Focus on Tools & Topics
                Research Funded by NINDS
                Research at NINDS
                Scientific Resources
                Trans-Agency Activities
                News & Events
                                     Toggle News & Events Dropdown
                                Events
                News
                Director's Messages
                About NINDS
                                     Toggle About NINDS Dropdown
                                Who We Are
                What We Do
                Job Opportunities 
 Home
                                Health Information
SHARE: Neuromyelitis Optica
On this page

            What is neuromyelitis optica?

Neuromyelitis optica (NMO) is an autoimmune disease of the central nervous system (CNS) that mainly affects the optic nerves and spinal cord. It is sometimes referred to as NMO spectrum disorder or NMOSD.

In NMO, the body's immune system mistakenly attacks healthy cells and proteins in the body, most often those in the spinal cord and eyes. Symptoms include:

Optic neuritis, which causes pain in the eye and vision loss
	Transverse myelitis, which causes weakness or paralysis of arms and legs
	Numbness

Loss of bladder and bowel control
	Severe nausea and vomiting, with hiccups from involvement of a part of the brain that controls vomiting

The disease is caused by abnormal autoantibodies that bind (attach) to a protein called aquaporin-4, activating other parts of the immune system and causing inflammation and damage to cells. This also results in the loss of myelin (the fatty substance that acts as insulation around nerve fibers and helps nerve signals move from cell to cell) in the brain and spinal cord.

NMO is different from multiple sclerosis (MS). Attacks are usually more severe in NMO than in MS, and NMO is treated differently than MS. Most individuals with NMO experience clusters of attacks days to months or years apart, followed by partial recovery during periods of remission. Women are more often affected by NMO than men. African Americans are at greater risk of the disease. The onset of NMO varies from childhood to adulthood, with two peaks, one in childhood and the other in adults in their 40s.

There is no cure for NMO. The U.S. Food and Drug Administration (FDA) has approved three drug treatments (eculizumab, inebilizumab-cdon, and satralizumab-mwge) which can reduce the risk of relapses in adults who are anti-aquaporin-4 antibody positive.

NMO relapses and attacks are often treated with corticosteroid drugs and plasma exchange (also called plasmapheresis, a process used to remove harmful antibodies from the bloodstream). Immunosuppressvie drugs used to prevent attacks include mycophenolate mofetil, rituximab, and azathioprine. Pain, stiffness, muscle spasms, and bladder and bowel control problems can be managed with medications and therapies.

Individuals with major disability may require physical and occupational therapy, along with social services professionals to address complex rehabilitation needs. Most individuals with NMO have an unpredictable, relapsing course of disease with attacks occurring months or years apart. Disability is cumulative, the result of each attack damaging new areas of the central nervous system.

file-medical

Learn About Clinical Trials

Clinical trials are studies that allow us to learn more about disorders and improve care. They can help connect patients with new and upcoming treatment options.

How can I or my loved one help improve care for people with neuromyelitis optica?

Consider participating in a clinical trial so clinicians and scientists can learn more about NMO and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease.

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them.

For information about participating in clinical research visitNIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with NMO atClinicaltrials.gov.

Where can I find more information about neuromyelitis optica?

Information may be available from the following resources:

MedlinePlus

Multiple Sclerosis Foundation

National Eye Institute (NEI)

National Organization for Rare Disorders (NORD)

The Guthy-Jackson Charitable Foundation

The Sumaira Foundation Inc. (TSF)
book-open

Order publications from the NINDS Catalog

The NINDS Publication Catalog offers printed materials on neurological disorders for patients, health professionals, and the general public. All materials are free of charge, and a downloadable PDF version is also available for most publications. Health Information
  
    

    Disorders
                                                              
                    
                                      Glossary of Neurological Terms
    
            Order PublicationsClinical Trials
                                                              
                    
                                      Clinical Trials in the Spotlight
    
            Find NINDS Clinical TrialsPatient & Caregiver Education
                                                              
                    
                                      Brain Attack Coalition
    
            Brain DonationPublic Education
                                                              
                    
                                      Brain Basics
                                                              
                    
                                      Know Your Brain
    
            Understanding Sleep
    
            Preventing Stroke
    
            The Life and Death of a Neuron
    
            Genes and the BrainKnow Stroke
                                                              
                    
                                      Health Professionals
                                                              
                    
                                      NIH Stroke ScalePatients and Caregivers
    
            Researchers
    
            Shareable Resources
                                                              
                    
                                      Recursos en EspañolMigraine Trainer® App
                                                              
                    
                                      Migraine Trainer® Shareable ResourcesMind Your Risks®
    
            NINDS Brain Educational Resources
        
  
              
    
            Support Resources
                                                              
                    
                                      Patient Organizations
    
            Professional Societies
    
            Government Resources

Did you find the content you were looking for?
  Yes, I did find the content I was looking for



No, I did not find the content I was looking forPlease rate how easy it was to navigate the NINDS website
  Very easy to navigate



Easy to navigate



Neutral



Difficult to navigate



Very difficult to navigateThank you for letting us know! Any other feedback?Submit

This site is protected by reCAPTCHA and the Google Privacy Policyand Terms of Serviceapply.

      Last reviewed on November 28, 2023
        Contact Us
  

        
              Contact NINDS
                Visitor Information
        Related Sites
  

        
              Site Map
                National Institutes of Health
                Department of Health & Human Services
                USA.gov
        Policies
  

        
              Accessibility
                Freedom of Information Act
                Linking Policy
                Privacy Statement
                Vulnerability Disclosure Policy
Follow NINDS On Social Media
          
          National Institutes of Health (NIH)
          9000 Rockville Pike, Bethesda, MD, 20892